| Thursday | ||||
Virtual Meeting to be… Virtual Meeting to be held on April 8 hosted by BTIG. | ||||
| Wednesday | ||||
LifeMD announced the… LifeMD announced the successful launch of NavaMD. The NavaMD website went live at the end of the first quarter of fiscal 2021 and is the company's personalized tele-dermatology brand and clinic, offering services to patients across all 50 states. NavaMD's services will be available to any patient seeking dermatology services. Service offerings include the diagnosis and treatment of prevalent skin conditions such as acne, rosacea, hyperpigmentation, signs of aging, and other prevalent skin conditions. NavaMD's customer acquisition strategy will be primarily set to growing its female customer base, fully supported by best-in-class direct response marketing, social media, and influencer campaigns. | ||||
| Over a week ago | ||||
Virtual Meeting to be… Virtual Meeting to be held on April 8 hosted by BTIG. | ||||
B. Riley Securities… B. Riley Securities analyst Andrew D'Silva reiterates a Buy rating on LifeMD with a $35 price target after spending time with management. Operations across the company's different brands appear to be charting more favorably than expected, D'Silva tells investors in a research note. LifeMD seen consolidated sales across its men's health brand, Rex MD, hair loss brand, Shapiro MD, and software-as-a-service-based PDF conversion software solution, PDFSimpli, accelerate, says the analyst. | ||||
| Over a month ago | ||||
Check out this morning's…
| ||||
LifeMD expects revenue… LifeMD expects revenue for the first quarter ending March 31, 2021 to exceed $17M, up more than 295% compared to the same year-ago quarter. "Given the strengthening sales and customer growth we've been seeing over the last few months, we are well on track for another record-breaking quarter that will once again exceed all expectations," stated LifeMD CEO, Justin Schreiber. "We are now hitting an annualized run-rate of more than $68 million, with increasing momentum coming into March. Our growing recurring revenue stream from subscriptions is also providing us greater visibility into future performance." Subscriptions are expected to generate more than 80% of revenue in the quarter, compared to about 63% in the same year-ago period. The increase in subscription revenue is expected to be largely due to sales of the company's Shapiro MD hair products for men and women under a new subscription-based program, as well as continued record subscription sales of the company's telemedicine brand for men, Rex MD. | |
New option listings for… New option listings for February 22nd include LifeMD Inc (LFMD). Option delistings effective February 22nd include Adicet Bio (ACET), Cellular Biomedicine Group Inc (CBMG), Chesapeake Energy Corp (CHKAQ), Old Copper Company Inc (CPPRQ), Conversion Labs Inc (CVLB), Organovo (ONVO), SouFun (SFUN), Stein Mart Inc (SMRTQ), Superior Energy Services Inc (SPNX), and Voxeljet (VJET). | |
Conversion Labs (CVLB)… Conversion Labs (CVLB) will begin trading at the opening of the market under its new name, LifeMD and Nasdaq ticker symbol (LFMD). The stock's new CUSIP number will be 53216B 104. The new name also heralds the upcoming official launch of LifeMD, the company's new subscription-based primary care and concierge service. The company recently introduced a new subscription-based service for its Shapiro MD hair products for men and women like it did for its Rex MD product line early last year. The company is also set to launch Nava MD, a new teledermatology brand for women delivered by a patented OTC technology platform. |